Findings from two randomized, vehicle-controlled trials showed a nonsteroidal topical treatment effectively improved psoriasis, including in difficult-to-treat areas. Mark Lebwohl, MD, discussed the implications of these findings in an interview with The Dermatologist.
A recent systematic review analyzed the role of multidisciplinary clinics for the treatment of patients with psychocutaneous diseases, including delusional infestation. Corresponding author Mohammad Jafferany, MD, discussed these findings further in an interview with The Dermatologist.
Tuberous sclerosis complex (TSC) is a rare, multiorgan, genetic disease with many cutaneous findings. In an interview with The Dermatologist, Elizabeth Thiele, MD, PhD, director of the TSC Center at Harvard Medical School, discusses common cutaneous symptoms of this disease.
A recent study found clinical trials that assessed the safety and efficacy of atopic dermatitis treatment rarely included older adults, with some even excluding patients younger than 60 years. Corresponding author Aaron Drucker, MD, discussed these findings and the importance of including older adults in trials for clinical practice.
Jesse Veenstra, MD, PhD, discussed the findings from the recent Henry Ford Health System study on the risk of COVID-19 infection and severe outcomes among patients with immune-mediated inflammatory diseases treated with immunosuppressive therapies.
A recent study highlighted several common patient-reported symptoms of hidradenitis suppurativa flares, including pain and drainage. In an interview with The Dermatologist, study authors Jennifer M. Fernandez, RD, and Vivian Shi, MD, discussed these findings and their implications for clinical practice.
A new large-scale study is underway to assess the impact of systemic therapies on COVID-19 among patients with atopic dermatitis and psoriasis. Dr Emma Guttman discusses the goals of the study and how it could help shape COVID-19 treatment among patients with inflammatory skin diseases.
Findings from a recent study showed tape strips may be a minimally invasive alternative to skin biopsies. Emma Guttman, MD, PhD, discussed these findings and their implications for clinical trials and practice.
When it comes to dermatology fellowship programs, accessible information may be the difference between candidates applying or not applying to their perfect “match.” Chapman Wei, BS, and Adam Friedman, MD, FAAD, discuss the importance of dermatology programs updating their websites to include more thorough descriptions and information regarding their programs, especially in the context of the current pandemic.